National Health Investors Receives a Hold from KeyBanc

By Ryan Adsit

KeyBanc analyst Jordan Sadler reiterated a Hold rating on National Health Investors (NYSE: NHI) on September 15. The company’s shares closed on Friday at $79.99, close to its 52-week high of $81.29.

According to, Sadler is a 4-star analyst with an average return of 4.2% and a 60.5% success rate. Sadler covers the Financial sector, focusing on stocks such as Apartment Investment & Management, National Storage Affiliates Trust, and Retail Properties of America Inc.

Currently, the analyst consensus on National Health Investors is Moderate Buy and the average price target is $82.33, representing a 2.9% upside.

In a report issued on September 4, BMO Capital also reiterated a Hold rating on the stock with a $80 price target.

The company has a one year high of $81.29 and a one year low of $66.31. Currently, National Health Investors has an average volume of 220.2K.

Based on the recent corporate insider activity of 9 insiders, corporate insider sentiment is neutral on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes independent and assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.